The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Palmer Ashleigh since year 2005.
The trader's CIK number is 1493714.
At the time of this reporting, Palmer Ashleigh is the President & CEO of Unigene Laboratories Inc .
(stock ticker symbol UGNE).
See this page for all insider trading activities at Unigene Laboratories Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2011-12-21||UGNE||Unigene Laboratories Inc||Buy||10,000||.53||5,280|
|2010-09-20||UGNE||Unigene Laboratories Inc||Buy||8,800||.70||6,160|
|2010-08-12||UGNE||Unigene Laboratories Inc||Buy||20,000||.60||12,000|
|2010-06-18||UGNE||Unigene Laboratories Inc||Buy||21,200||.78||16,642|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Palmer Ashleigh (President & CEO of Unigene Laboratories Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.